When should progesterone levels be checked?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

When to Check Progesterone Levels

Progesterone levels should be checked in women with singleton pregnancies and prior spontaneous preterm birth (SPTB) at 16-20 weeks gestation, and in women with singleton pregnancies without prior SPTB but with short cervical length (≤20 mm) at 18-24 weeks gestation. 1

Indications for Progesterone Level Testing

Preterm Birth Prevention

  • For women with singleton pregnancies and history of prior spontaneous preterm birth (SPTB), progesterone levels should be checked at 16-20 weeks gestation before initiating 17-alpha-hydroxyprogesterone caproate (17P) therapy 1
  • For women with singleton pregnancies without prior SPTB but with short cervical length (≤20 mm) identified on transvaginal ultrasound at 18-24 weeks, progesterone levels should be checked before starting vaginal progesterone therapy 1

First Trimester Pregnancy Viability Assessment

  • Serum progesterone can be used as a diagnostic tool in symptomatic first-trimester pregnant patients with pain or bleeding to assess pregnancy viability 2, 3
  • A single progesterone level <6.3 ng/mL (<20.034 nmol/L) has high specificity (99.2%) for non-viable pregnancy, while levels ≥20-25 ng/mL (63.6-79.5 nmol/L) are associated with viable pregnancies (91.3% sensitivity) 3

Threatened Miscarriage

  • In women presenting with threatened miscarriage, progesterone levels should be checked as they are typically about 10 nmol/L lower than in normal pregnancies at the same gestational age 2
  • Progesterone levels below 10 ng/mL prior to 10 weeks gestation indicate subnormal corpus luteum function and may warrant hormone treatment in patients with bleeding in early pregnancy 4

Timing of Progesterone Testing

For Preterm Birth Prevention

  • 16-20 weeks gestation for women with prior SPTB 1
  • 18-24 weeks gestation for women undergoing cervical length screening 1

For Pregnancy Viability Assessment

  • As early as 14 days post-oocyte retrieval in IVF/ICSI cycles (approximately 4 weeks gestation) 5
  • Between 5-13 weeks gestation for women with threatened miscarriage symptoms 2

Interpretation of Progesterone Levels

  • Normal progesterone levels increase linearly from approximately 57.5 nmol/L at 5 weeks to 80.8 nmol/L at 13 weeks gestation in normal pregnancies 2
  • A transient decline in progesterone levels may be observed between 6-8 weeks gestation, corresponding to the luteal-placental shift, with lowest levels typically seen at week 7 6
  • In IVF/ICSI cycles, women with ongoing pregnancies at 8 weeks typically have significantly higher serum progesterone levels (median: 430 nmol/L) compared to those with abnormal pregnancies (72 nmol/L) 5

Clinical Pitfalls and Caveats

  • Progesterone testing should be performed with proper technique to yield accurate results, with quality control and monitoring 1
  • Maternal factors including age, BMI, and parity can influence progesterone levels and should be considered when interpreting results 6
  • For women receiving exogenous progesterone supplementation, timing of blood collection relative to administration can affect measured levels 5
  • In artificial cycles for frozen embryo transfer, progesterone supplementation begins on the day of endometrial transformation and should be continued for 3-4 weeks after pregnancy confirmation 1

Treatment Based on Progesterone Levels

  • For women with singleton pregnancies and prior SPTB: 17P 250 mg IM weekly from 16-20 weeks until 36 weeks 1
  • For women with singleton pregnancies without prior SPTB but with short cervical length (≤20 mm): vaginal progesterone 90-mg gel or 200-mg suppository daily from diagnosis until 36 weeks 1
  • For threatened miscarriage with low progesterone: oral progesterone 400 mg daily may be considered, although evidence is less robust than for vaginal administration 7

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.